share_log

赛隆药业:第四届董事会审计委员会2024年第三次会议的审查意见

Sailong Pharmaceutical: Review Opinions of the Third Meeting of the Fourth Board Audit Committee in 2024

SZSI ·  Oct 31
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more